Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura L Gillison

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
The Journal of Infectious Diseases|December 10, 2013
Prevalence of cervical and oral human papillomavirus infections among US womenMartin Steinau, Susan Hariri, Maura L Gillison, et al.
Cancer Research|April 16, 2015
NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. MenAnil K Chaturvedi, Barry I Graubard, Tatevik Broutian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2017
Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United StatesAnil K Chaturvedi, Barry I Graubard, Tatevik Broutian, et al.
International Journal of Cancer|March 14, 2007
Six-month natural history of oral versus cervical human papillomavirus infectionGypsyamber D'Souza, Carole Fakhry, Elizabeth A Sugar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2014
Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partnersGypsyamber D'Souza, Neil D Gross, Sara I Pai, et al.
Plos Genetics|January 25, 2018
HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expressionAlix Warburton, Catherine J Redmond, Katharine E Dooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancerMaura L Gillison, Qiang Zhang, Richard Jordan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2013
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancersAnil K Chaturvedi, William F Anderson, Joannie Lortet-Tieulent, et al.
The American Journal of Surgical Pathology|June 30, 2012
Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trialsRichard C Jordan, Mark W Lingen, Bayardo Perez-Ordonez, et al.
Cancer|August 28, 2019
Development and validation of an individualized risk prediction model for oropharynx cancer in the US populationJoseph E Tota, Maura L Gillison, Hormuzd A Katki, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
The Journal of Infectious Diseases|December 10, 2013
Prevalence of cervical and oral human papillomavirus infections among US womenMartin Steinau, Susan Hariri, Maura L Gillison, et al.
Cancer Research|April 16, 2015
NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. MenAnil K Chaturvedi, Barry I Graubard, Tatevik Broutian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2017
Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United StatesAnil K Chaturvedi, Barry I Graubard, Tatevik Broutian, et al.
International Journal of Cancer|March 14, 2007
Six-month natural history of oral versus cervical human papillomavirus infectionGypsyamber D'Souza, Carole Fakhry, Elizabeth A Sugar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2014
Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partnersGypsyamber D'Souza, Neil D Gross, Sara I Pai, et al.
Plos Genetics|January 25, 2018
HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expressionAlix Warburton, Catherine J Redmond, Katharine E Dooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancerMaura L Gillison, Qiang Zhang, Richard Jordan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2013
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancersAnil K Chaturvedi, William F Anderson, Joannie Lortet-Tieulent, et al.
The American Journal of Surgical Pathology|June 30, 2012
Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trialsRichard C Jordan, Mark W Lingen, Bayardo Perez-Ordonez, et al.
Cancer|August 28, 2019
Development and validation of an individualized risk prediction model for oropharynx cancer in the US populationJoseph E Tota, Maura L Gillison, Hormuzd A Katki, et al.
Pageof 16